Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Pharmacol Ther. 2015 Dec 2;158:63–70. doi: 10.1016/j.pharmthera.2015.11.013

Figure 2.

Figure 2

Mutational landscape of regulators of the PI3K/AKT pathway in breast cancer. A. Copy-number and mutational data on ERBB2, PIK3CA, AKT 1–3 and phosphatases PTEN and INPP4B in breast cancer (TCGA, 2015). B. Mutation rates of the genes encoding these components in ERBB2-amplified breast cancer show that, after PI3K coding-gene, the gene encoding AKT3 is the most frequently altered, mainly by means of copy number gain.